S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|StemCells, Inc. Launches Alzheimer's Disease Program Supported by California Institute for Regenerative Medicine ()|
|StemCells, Inc. Executive Vice President Ann Tsukamoto, Ph.D., to Make Keynote Address at 2013 Stem Cell Meeting on the Mesa's Scientific Symposium (2013/10/10)|
|StemCells, Inc. Appoints Greg Schiffman as Chief Financial Officer (2013/11/14)|
|StemCells, Inc. Publishes Comprehensive Review of Results From HuCNS-SC Clinical Trials (2013/9/9)|
|StemCells, Inc. Presents Two-Year Pelizaeus-Merzbacher Disease (PMD) Data Suggesting Departure From Natural History of the Disease (2013/8/2)|
|StemCells, Inc. Receives FDA Authorization of IND for Spinal Cord Injury (2013/10/2)|
|StemCells, Inc. to Present at 2013 Stem Cell Meeting on the Mesa's Regen Med Partnering Forum (2013/10/9)|
|StemCells, Inc. Announces Results of Long-Term Follow-Up Study in Batten Disease (2013/10/21)|
|StemCells, Inc. Acquires Seminal Neural Stem Cell Patent Portfolio (2013/10/29)|
|StemCells, Inc. Announces Webcast to Discuss Second Quarter 2013 Financial Results and Business Update (2013/8/5)|
Click above to view more mutual fund data and stats for stem - StemCells, Inc..